- Investing Ideas
- Argentinian Pharmaceuticals & Biotech Potentially Undervalued Companies
Argentinian Pharmaceuticals & Biotech Potentially Undervalued Companies
Results
19
Companies with a Value score of at least 3, ordered by Value score
19 companies
Gilead Sciences
Market Cap: AR$183.0b
A biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally.
GILD
AR$56,925.00
7D
4.1%
1Y
48.7%
Bristol-Myers Squibb
Market Cap: AR$138.1b
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, markets, distributes, and sells biopharmaceutical products worldwide.
BMY
AR$34,620.00
7D
1.5%
1Y
62.7%
Bristol-Myers Squibb
Market Cap: US$138.1b
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, markets, distributes, and sells biopharmaceutical products worldwide.
BMYD
US$23.49
7D
6.9%
1Y
n/a
Bayer
Market Cap: AR$47.7b
Operates as a life science company in Europe, the Middle East, Africa, Germany, Switzerland, North America, the United States, the Asia Pacific, China, Latin America, and Brazil.
BAYN
AR$31,000.00
7D
14.7%
1Y
n/a
Novo Nordisk
Market Cap: US$1.3t
Engages in the research and development, manufacture, and distribution of pharmaceutical products.
NVOD
US$6.93
7D
0.9%
1Y
n/a
Novo Nordisk
Market Cap: AR$1.3t
Engages in the research and development, manufacture, and distribution of pharmaceutical products.
NVO
AR$10,450.00
7D
-0.9%
1Y
n/a
GSK
Market Cap: US$77.0b
Engages in the research, development, and manufacture of vaccines, specialty medicines, and general medicines to prevent and treat disease in the United Kingdom, the United States, and internationally.
GSKD
US$13.54
7D
5.2%
1Y
35.4%
GSK
Market Cap: AR$77.0b
Engages in the research, development, and manufacture of vaccines, specialty medicines, and general medicines to prevent and treat disease in the United Kingdom, the United States, and internationally.
GSK
AR$20,630.00
7D
3.6%
1Y
56.3%
Gilead Sciences
Market Cap: US$183.0b
A biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally.
GILDD
US$37.76
7D
5.7%
1Y
26.9%
Amgen
Market Cap: US$239.2b
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide.
AMGND
US$14.92
7D
3.7%
1Y
50.4%
AstraZeneca
Market Cap: AR$187.5b
A biopharmaceutical company, focuses on the discovery, development, manufacture, and commercialization of prescription medicines.
AZN
AR$65,350.00
7D
5.1%
1Y
23.2%
Biogen
Market Cap: AR$32.7b
Biogen Inc. discovers, develops, manufactures, and delivers therapies in the United States, Europe, Germany, Asia, and internationally.
BIIB
AR$26,180.00
7D
1.8%
1Y
85.7%
Biogen
Market Cap: US$32.7b
Biogen Inc. discovers, develops, manufactures, and delivers therapies in the United States, Europe, Germany, Asia, and internationally.
BIIBD
US$17.30
7D
2.8%
1Y
61.7%
Amgen
Market Cap: AR$239.2b
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide.
AMGN
AR$22,910.00
7D
4.0%
1Y
75.6%
Vertex Pharmaceuticals
Market Cap: AR$139.9b
Operates as a biotechnology company in the United States, Europe, and internationally.
VRTX
AR$8,445.00
7D
4.5%
1Y
62.7%
Vertex Pharmaceuticals
Market Cap: US$139.9b
Operates as a biotechnology company in the United States, Europe, and internationally.
VRTXD
US$5.62
7D
6.2%
1Y
46.2%
Novartis
Market Cap: AR$240.1b
Researches, develops, manufactures, distributes, markets, and sells pharmaceutical medicines in Switzerland and internationally.
NVS
AR$61,825.00
7D
2.8%
1Y
47.8%
Novartis
Market Cap: US$240.1b
Researches, develops, manufactures, distributes, markets, and sells pharmaceutical medicines in Switzerland and internationally.
NVSD
US$41.01
7D
6.1%
1Y
29.2%
AstraZeneca
Market Cap: US$187.5b
A biopharmaceutical company, focuses on the discovery, development, manufacture, and commercialization of prescription medicines.
AZND
US$42.62
7D
4.0%
1Y
5.1%